+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
From
Hemophilia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hemophilia Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
From
From
Plasma-Derived Medicines Market - Global Strategic Business Report - Product Thumbnail Image

Plasma-Derived Medicines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 391 Pages
  • Global
From
Hemostasis Products Market Report 2025 - Product Thumbnail Image

Hemostasis Products Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Hemophilia Market Report 2025 - Product Thumbnail Image

Hemophilia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Hepatitis A immunoglobulin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Hepatitis A immunoglobulin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Loading Indicator